ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 639 filers reported holding ASTRAZENECA PLC in Q4 2019. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $4,774,000 | +18.6% | 71,963 | +4.1% | 0.20% | +25.9% |
Q4 2021 | $4,026,000 | -3.8% | 69,118 | -0.8% | 0.16% | -10.0% |
Q3 2021 | $4,185,000 | +1.4% | 69,688 | +1.1% | 0.18% | +1.1% |
Q2 2021 | $4,128,000 | +27.5% | 68,908 | +5.9% | 0.18% | +16.3% |
Q1 2021 | $3,237,000 | +5.9% | 65,098 | +6.5% | 0.15% | +0.7% |
Q4 2020 | $3,056,000 | -4.2% | 61,123 | +5.0% | 0.15% | -19.1% |
Q3 2020 | $3,191,000 | +4.2% | 58,224 | +0.6% | 0.19% | -3.6% |
Q2 2020 | $3,061,000 | +16.8% | 57,874 | -1.4% | 0.20% | -1.0% |
Q1 2020 | $2,621,000 | -10.6% | 58,677 | -0.2% | 0.20% | +10.7% |
Q4 2019 | $2,933,000 | +11.6% | 58,817 | -0.3% | 0.18% | +4.1% |
Q3 2019 | $2,629,000 | +9.5% | 58,982 | +1.4% | 0.17% | +7.5% |
Q2 2019 | $2,401,000 | +1.9% | 58,162 | -0.2% | 0.16% | +0.6% |
Q1 2019 | $2,357,000 | -33.2% | 58,297 | -37.3% | 0.16% | -41.5% |
Q4 2018 | $3,530,000 | -4.9% | 92,943 | -0.9% | 0.27% | +8.4% |
Q3 2018 | $3,711,000 | +7.7% | 93,778 | -4.4% | 0.25% | +0.4% |
Q2 2018 | $3,445,000 | -3.1% | 98,128 | -3.5% | 0.25% | -5.0% |
Q1 2018 | $3,557,000 | -8.3% | 101,716 | -9.0% | 0.26% | -6.8% |
Q4 2017 | $3,877,000 | +8.7% | 111,715 | +6.1% | 0.28% | +4.9% |
Q3 2017 | $3,568,000 | +3.9% | 105,320 | +4.5% | 0.27% | -1.1% |
Q2 2017 | $3,435,000 | +12.0% | 100,770 | +2.3% | 0.27% | +9.3% |
Q1 2017 | $3,067,000 | +19.5% | 98,490 | +4.9% | 0.25% | +12.3% |
Q4 2016 | $2,566,000 | -20.1% | 93,908 | -3.9% | 0.22% | -21.4% |
Q3 2016 | $3,212,000 | +9.7% | 97,738 | +0.8% | 0.28% | +6.9% |
Q2 2016 | $2,927,000 | +12.2% | 96,968 | +4.7% | 0.26% | +5.2% |
Q1 2016 | $2,608,000 | -12.9% | 92,628 | +5.0% | 0.25% | -14.7% |
Q4 2015 | $2,994,000 | +13.8% | 88,203 | +6.7% | 0.29% | +5.8% |
Q3 2015 | $2,632,000 | -7.7% | 82,703 | +84.8% | 0.28% | -0.4% |
Q2 2015 | $2,851,000 | -5.0% | 44,744 | +2.1% | 0.28% | -4.8% |
Q1 2015 | $3,000,000 | +73.0% | 43,844 | +77.9% | 0.29% | +62.6% |
Q4 2014 | $1,734,000 | +8.6% | 24,642 | +10.2% | 0.18% | +2.3% |
Q3 2014 | $1,597,000 | +3.6% | 22,357 | +7.7% | 0.18% | +1.7% |
Q2 2014 | $1,542,000 | +20.6% | 20,757 | +5.3% | 0.17% | +11.7% |
Q1 2014 | $1,279,000 | +10.7% | 19,714 | +1.3% | 0.15% | +11.6% |
Q4 2013 | $1,155,000 | – | 19,455 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |